255 related articles for article (PubMed ID: 31088361)
1. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
Caubet Fernandez M; Drouin S; Samoilenko M; Morel S; Krajinovic M; Laverdière C; Sinnett D; Levy E; Marcil V; Lefebvre G
BMC Med Res Methodol; 2019 May; 19(1):100. PubMed ID: 31088361
[TBL] [Abstract][Full Text] [Related]
2. Predictors of low and very low bone mineral density in long-term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction.
Nadeau G; Samoilenko M; Fiscaletti M; Veilleux LN; Curnier D; Laverdière C; Sinnett D; Krajinovic M; Lefebvre G; Alos N
Pediatr Blood Cancer; 2024 May; ():e31047. PubMed ID: 38736190
[TBL] [Abstract][Full Text] [Related]
3. Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.
England J; Drouin S; Beaulieu P; St-Onge P; Krajinovic M; Laverdière C; Levy E; Marcil V; Sinnett D
BMC Cancer; 2017 Nov; 17(1):751. PubMed ID: 29126409
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.
Geneviève N; Mojgan Y; Nahid Y; Vincenzo F; Simon G; Daniel S; Maja K; Nathalie A; Despoina M
J Bone Miner Res; 2024 Mar; 39(2):130-138. PubMed ID: 38477791
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
Richard MA; Brown AL; Belmont JW; Scheurer ME; Arroyo VM; Foster KL; Kern KD; Hudson MM; Leisenring WM; Okcu MF; Sapkota Y; Yasui Y; Morton LM; Chanock SJ; Robison LL; Armstrong GT; Bhatia S; Oeffinger KC; Lupo PJ; Kamdar KY
Cancer; 2021 Jan; 127(2):310-318. PubMed ID: 33048379
[TBL] [Abstract][Full Text] [Related]
6. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation.
Sklar CA; Mertens AC; Walter A; Mitchell D; Nesbit ME; O'Leary M; Hutchinson R; Meadows AT; Robison LL
Med Pediatr Oncol; 2000 Aug; 35(2):91-5. PubMed ID: 10918229
[TBL] [Abstract][Full Text] [Related]
7. Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†.
Green DM; Zhu L; Wang M; Chemaitilly W; Srivastava D; Kutteh WH; Ke RW; Sklar CA; Pui CH; Kun LE; Ribeiro RC; Robison LL; Hudson MM
Hum Reprod; 2017 Jun; 32(6):1192-1201. PubMed ID: 28444255
[TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic Risk Factors in Childhood, Adolescent and Young Adult Survivors of Acute Lymphoblastic Leukemia - A Petale Cohort.
Levy E; Samoilenko M; Morel S; England J; Amre D; Bertout L; Drouin S; Laverdière C; Krajinovic M; Sinnett D; Lefebvre G; Marcil V
Sci Rep; 2017 Dec; 7(1):17684. PubMed ID: 29247169
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.
Oeffinger KC; Adams-Huet B; Victor RG; Church TS; Snell PG; Dunn AL; Eshelman-Kent DA; Ross R; Janiszewski PM; Turoff AJ; Brooks S; Vega GL
J Clin Oncol; 2009 Aug; 27(22):3698-704. PubMed ID: 19564534
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.
Follin C; Erfurth EM
Curr Treat Options Oncol; 2016 Sep; 17(9):50. PubMed ID: 27476159
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia.
Oeffinger KC; Buchanan GR; Eshelman DA; Denke MA; Andrews TC; Germak JA; Tomlinson GE; Snell LE; Foster BM
J Pediatr Hematol Oncol; 2001 Oct; 23(7):424-30. PubMed ID: 11878576
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.
Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W
Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723
[TBL] [Abstract][Full Text] [Related]
13. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
14. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia.
Tonorezos ES; Vega GL; Sklar CA; Chou JF; Moskowitz CS; Mo Q; Church TS; Ross R; Janiszewski PM; Oeffinger KC
Pediatr Blood Cancer; 2012 Jan; 58(1):31-6. PubMed ID: 21254377
[TBL] [Abstract][Full Text] [Related]
15. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
17. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
Follin C; Erfurth EM; Johansson A; Lätt J; Sundgren PC; Österberg K; Spulber G; Mannfolk P; Björkman-Burtscher IM
Psychoneuroendocrinology; 2016 Nov; 73():157-165. PubMed ID: 27498291
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
19. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
